The artisan-crafted furnishings brand debuts its first Montana location at Bozeman’s Gallatin Crossing BOSTON HEIGHTS, Ohio, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arhaus (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, today announced the opening of its new 12,006-square-foot showroom in Bozeman, Montana. Located in Gallatin Crossing—Bozeman’s premier shopping and lifestyle destination surrounded by sweeping mountain views—the new showroom marks Ar ...

ZUG, Switzerland, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) will release its third quarter 2025 earnings results before market open on Monday, November 10, 2025. In conjunction, the Company will also release the results of the Scoping Study (“Scoping Study”) for the Pozuelos-Pastos Grandes lithium brine project (“PPG”) in the Province of Salta, Argentina. The Company will host a webcast and conference call on Monday, November 10, 202 ...

MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering of 5,233,765 shares of its Class A common stock, which includes the exercise in full of the underwriters’ option to purchase an additional 682,665 shares of Class A common stock at a public offering price of $60.00 per share, less underwriting discounts and ...

Company expects to host a webcast to discuss the topline data on Monday, November 10 at 8:00 AM EST / 2:00 PM CETCompany also expects to publish third quarter 2025 financial results on the same day pre-market JENA, Germany, Nov. 07, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it expects to report topline data from the Phase 2a clinical trial of oral C5aR inhibitor INF904 i ...

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Business HighlightsSurrozen remains focused on its ophthalmology pipeline, leveraging its Wnt biology ...

Core Insights - Nanox Imaging Ltd will report its financial results for Q3 2025 on November 20, 2025, before market open [1] - The conference call to discuss these results will be hosted by CEO Erez Meltzer and CFO Ran Daniel at 8:30 a.m. ET [1] Company Overview - Nanox is focused on transitioning to preventive healthcare through affordable medical imaging technologies utilizing advanced AI and proprietary digital X-ray sources [3] - The company's vision includes expanding its technology's reach beyond hospitals, providing a comprehensive solution from scan to diagnosis, and leveraging AI for improved diagnostic accuracy [4] Product Ecosystem - Nanox.ARC is a multi-source digital tomosynthesis system designed to be cost-effective and user-friendly [4] - Nanox.AI LTD offers an AI-based suite of algorithms that enhance routine CT imaging readings to detect early signs of chronic diseases [4] - Nanox.CLOUD is a cloud-based platform for managing data from Nanox devices, providing tools for in-depth imaging analysis [4] - Nanox.MARKETPLACE is a decentralized marketplace that offers remote access to radiology and cardiology experts, along with a teleradiology services platform [4]

-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the third quarter of 2025. “We are very pleased with our performance for the third quarter of 2025.” said T.J. Schaefer, CEO ...

WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company presented data, including results from the first real-world study of XPHOZAH, at American Society of Nephrology’s Kidney Week, currently underway in Houston. XPHOZAH is the first and only phosphate absorption inhibitor (PAI) appr ...

CARLSBAD, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today published its second quarter fiscal year 2026 financial results in a letter to shareholders, which, along with webcast slides, is now posted to the Investor Relations section of Viasat’s website. As previously announced, Viasat will host a conference call today, Friday, November 7, 2025 at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time. To participate on the live conference ca ...

Hong Kong, China, Nov. 07, 2025 (GLOBE NEWSWIRE) -- New Century Logistics (BVI) Limited (hereinafter referred to as “New Century” or the “Company”), a company listed on the NASDAQ, reported that it expects to implement a 1-for-8 reverse stock split on its common stock. The effective date is scheduled to be Friday, November 14, 2025, subject to the Company’s satisfaction of Nasdaq Operations notice requirements, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the co ...